Skip to Primary Navigation Skip to Site Navigation Skip to Main Content

Transdermal & Microneedle Technologies

Delivering a wide range of APIs with in patient- and manufacturer-friendly formats

With more than 30 years of transdermal experience, 3M excels at integrating adhesive, drug and components into a single, simple system that provides superior product stability and optimal system performance throughout the duration of the wear period. We deliver the core advantages you need to help ensure your technical success:
  • Expertise in customizing solutions to fit drug formulation needs
  • Access to material and process technology expertise from across the 3M scientific community
  • Regulatory and toxicology support
  • Streamlined pathway through development
  • Global manufacturing services

sTMS on the arm
3M Transdermal Technologies System


In addition, the 3M Microstructured Transdermal Systems (MTS) mirconeedle platform combines the efficiency of a syringe with the convenience of a transdermal device to expand the range of transdermally deliverable drugs.

  • Local or systemic delivery for both large and difficult to deliver molecules, including proteins, peptides and vaccines
  • Improves delivery efficiency and absorption time of some drugs and vaccines
  • Potential for dose sparing – important for high-value biologics
  • Capability to enhance stability for some drugs
  • Available in a solid or hollow design to meet the needs of your program

Passive Transdermal Technology
Transdermal Componentry
Microneedle Technology
Posters, Presentations & Publications

Contact Us
Exhibitions and Conferences

BIO
June 18 - 21, 2012
Boston, MA

Medical Design & Manufacturing East (MD&M East)
May 22-24, 2012
Philadelphia, PA

Microneedles
May 13-15, 2012
Cork, Ireland


See all events